000 01359 a2200445 4500
005 20250516125827.0
264 0 _c20130703
008 201307s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2012.09.085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOgilvie, G S
245 0 0 _aPopulation-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
_h[electronic resource]
260 _bVaccine
_cFeb 2013
300 _a1129-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBritish Columbia
_xepidemiology
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPapillomaviridae
_xclassification
650 0 4 _aPapillomavirus Infections
_xepidemiology
650 0 4 _aPrevalence
650 0 4 _aYoung Adult
700 1 _aCook, D A
700 1 _aTaylor, D L
700 1 _aRank, C
700 1 _aKan, L
700 1 _aYu, A
700 1 _aMei, W
700 1 _avan Niekerk, D J
700 1 _aColdman, A J
700 1 _aKrajden, M
773 0 _tVaccine
_gvol. 31
_gno. 7
_gp. 1129-33
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2012.09.085
_zAvailable from publisher's website
999 _c22378013
_d22378013